发明名称 |
REDUCTION OF ADVERSE EVENTS AFTER PERCUTANEOUS INTERVENTION BY USE OF A THROMBIN RECEPTOR ANTAGONIST |
摘要 |
Disclosed are methods of preventing adverse clinical events in a patient undergoing a percutaneous coronary intervention procedure or a peripheral percutaneous interventional procedure comprising administering a therapeutically effective amount of a thrombin receptor antagonist, such as SCH 530348, to the patient. Administration of a loading dose of about 40 mg of SCH 530348 in as little as one hour prior to the procedure can result in therapeutically effective levels of platelet aggregation.
|
申请公布号 |
US2008234236(A1) |
申请公布日期 |
2008.09.25 |
申请号 |
US20080051504 |
申请日期 |
2008.03.19 |
申请人 |
VELTRI ENRICO P;STRONY JOHN T;CHINTALA MADHU |
发明人 |
VELTRI ENRICO P.;STRONY JOHN T.;CHINTALA MADHU |
分类号 |
A61K31/443;A61K31/4365;A61K31/5377;A61K31/60 |
主分类号 |
A61K31/443 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|